Would be competitors for PD-1 refractory melanoma are: Idera (IDRA) IMO-2125 plus ipi or pembro Dynavax (DVAX) SD-101 + pembro Checkpoint CMP-001 + pembro All three combo trials will have data updates at AACR 1st week in April, DVAX is a late-breaker.